drugset / Trial / NCT02801071

L-Citrulline in Patients With Post-Polio Syndrome

NCT02801071

Phase 3 Completed 30 enrolled Dirk Fischer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to show that the intake of L-citrulline improves muscle function in patients with Post-Polio Syndrome (PPS).

Timeline

Start
2016-06-14
Primary completion
2017-08-15
Completion
2018-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject L-citrulline Other / unclassified 5 g Oral